{"name":"Wales Cancer Trials Unit","slug":"wales-cancer-trials-unit","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Zolendronic Acid","genericName":"Zolendronic Acid","slug":"zolendronic-acid","indication":"Hypercalcemia of malignancy","status":"marketed"}]}],"pipeline":[{"name":"Zolendronic Acid","genericName":"Zolendronic Acid","slug":"zolendronic-acid","phase":"marketed","mechanism":"Zoledronic acid inhibits osteoclast-mediated bone resorption by blocking farnesyl pyrophosphate synthase in the mevalonate pathway.","indications":["Hypercalcemia of malignancy","Bone metastases in solid tumors and multiple myeloma","Osteoporosis prevention in patients receiving aromatase inhibitors for breast cancer"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxPV3FEaXNpS1M3R1dvaW9ONkVWVE5CaElxd3lrckhuTElyem9mWm8zQkpXMGlIV2txUG5UaGJmajVpLTJlRlUzMEpoZzNLVm9wdTlwN25uN1lsSkdWSDNzakp1amRNOWMyenZ4X0tjSTZUdElvaXZ5SWwweHZham9nRmFvNmxDOXoyNm1MWmI5aXZYdzZsUHZxbXBqR1M5YXpnVGQzWFF6dTMtTk1uZ2NZdVJzQzd2Y21lckhTOUREallQb1VsYlpBOWJFbzA?oc=5","date":"2025-12-03","type":"pipeline","source":"Swansea Bay University Health Board","summary":"Cancer centre's pioneering research boosted with investment of more than £450,000 - Swansea Bay University Health Board","headline":"Cancer centre's pioneering research boosted with investment of more than £450,000","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxOeTlTcUVubXdLT0hRdFE4RFRNaUo3VG56MnhDV1hBWmRocUFXSC01T1ZwVHJEWmh1M1c4TEU5ZWpqUEJOSnZUbW5vS1Fwem9XZEhteFN6UF9WS2liMDNWQmRSMlV1Sng0N2xyWTRlZ1dTV2ZISXNLakZMd0x5allzdWJzR2pVYTRtcktrU3dxQUQ1aGQyczdmQWxjTU1rdGVjSThseHhwaE9YTlo0NDBqTWNzcXEwQ2VxeXBSLUIxN05NNnhybVhfTGF3?oc=5","date":"2025-12-01","type":"trial","source":"Swansea Bay University Health Board","summary":"Swansea first centre in Wales to join UK-wide skin cancer radiotherapy trial - Swansea Bay University Health Board","headline":"Swansea first centre in Wales to join UK-wide skin cancer radiotherapy trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0wFBVV95cUxNZTZtcWZHN29zSU5lYXY5T0E0aUd2MUNfVl9KRmlIZURzdkxidjV0NXlLdWM3LW1OajFqSjdyT2RObC05TTlhb3JKRkpERzJZbGJ6ekJyejN2Q1ZSWkxEUTNJVERENkgxeWNJejVzY0MxQVQwU1N1enBQQ2pUaTZLaXhqTWtpWkJ5VG5Yc2J1Qm1yYVg4Vm1GOTI1ajUwX0swRk1QWTNBQ2RwamE3RzNVaHRhTUs0TGJvMnM4bkdrWUR6cWRhcUV5aFZRd0twdGkxVXp3?oc=5","date":"2025-11-28","type":"trial","source":"The Pharmaceutical Journal","summary":"Boots partners with University of Oxford to pilot pharmacy recruitment to clinical trials - The Pharmaceutical Journal","headline":"Boots partners with University of Oxford to pilot pharmacy recruitment to clinical trials","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZEFVX3lxTE5ZeXRHY0luODN2Y2tZUGxSVE4xVnFlNWtuVmEyRnNadkFyVDBMUUVVNFA2SFN6MlVlX0plTFNoMzQ3dnpzZ1JUZERoOEFEOTJiY0tYMzk0NFluUEJWUU9KMW91VTc?oc=5","date":"2025-10-17","type":"pipeline","source":"Wiley Online Library","summary":"2025 MOGA Annual Scientific Meeting PROGRAM and ABSTRACTS - 2025 - Asia-Pacific Journal of Clinical Oncology - Wiley Online Library","headline":"2025 MOGA Annual Scientific Meeting PROGRAM and ABSTRACTS - 2025 - Asia-Pacific Journal of Clinical Oncology","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxPWUNjMTRPUTJVZHlvakNzVnVIdHpFSDN1NVN2M3JDX0psUlV6VlBvMjdGVklISndWWnJLcnlXRVBDdXp6Z0ZmbEFhekEzcEk0MEZ2WmNZa3h5T3lIRlU0TmtNUHQ3azVoUlRCZERGdHdDVFBXMDItUEZuLWNQYUFVNlRaQS0yUjB1OXZENmtLaENFMUZET3BxMjFYa2ppUktkZ2lmME1ZV1ZweGxaQmxRNmJtbHVFU29LNy1uUzVuVUVZRGFsclVF?oc=5","date":"2025-09-26","type":"trial","source":"The Association of the British Pharmaceutical Industry | ABPI","summary":"Making Wales a destination for industry clinical trials and medical research - The Association of the British Pharmaceutical Industry | ABPI","headline":"Making Wales a destination for industry clinical trials and medical research - The Association of the British Pharmaceut","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxQa1VQVHF4em9uaVZkcy1VUm83QndvcUY0a0dqQ0RPcXhMa0t3ZEljRUozQzZlNlpnUEhDdl9tR0EzTWdXQ0REYnpMejQ2VWYwbFhSQ1phZy1PY1Ixb25mRC1sMTZVSVpIMGdGMWJTaE91SnBzbUJyZzhzM1hNR3VFRzJCZ1hMdUNuZXY1M0ZCTmFYbm05RkpLam4tM1R1dHc3MmM1WWRDZmY1Q2ZTeVFNa2xQbVNEQ0ZhdExZ?oc=5","date":"2025-05-12","type":"pipeline","source":"Reuters","summary":"Nature has been my sanctuary during cancer treatment, UK princess Kate says - Reuters","headline":"Nature has been my sanctuary during cancer treatment, UK princess Kate says","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTFBIYWZKeEgwWEpoVkszVWs4eWFMX3Z3Mk5mYmJvdXZEeHA3ZFJVcFJhRnFwNFdnRFBmc1lDTjc1c09hWWlnVDJ3b0tJXzFDN3dqazc2ZDFFbDAyY0tCNFRIekt2UHZXZjdQcFcwZmdzZWduMGowRnZheE1R?oc=5","date":"2025-02-28","type":"trial","source":"Cancer Research UK - Cancer News","summary":"The DETERMINE trial: a timeline to treating the 100th patient - Cancer Research UK - Cancer News - Cancer Research UK - Cancer News","headline":"The DETERMINE trial: a timeline to treating the 100th patient - Cancer Research UK - Cancer News - Cancer Research UK","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxNcnpIVmtNZm1nZEo0UmMxRE1KX3RjMzlrX1NzUk5JTE1MY01nbS03bk10Tl9qWTZ4UnlOTnpvcktKUVdRRXdUUmpteU1pcDlOWHU1Q3ZyYWhtdW15Z2JseFU0emNCUmpmeGFGS0lsY3pCanBlaTJXSHBTVnVNczg5VFZ4T0ZIS0VIWGxZ?oc=5","date":"2022-08-20","type":"regulatory","source":"The Lancet","summary":"The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019 - The Lancet","headline":"The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Diseas","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFByODA5NzU2WmlEMnJMbFV5SlZfeTQtNVJ5OFNQODljdGNiWHZYbU9sbGx2b2MyZU93X3pFYVBnelFxX3NpTlVRRWlNWDh3ZEJETkhRUnA1N1UzSFlPZHpr?oc=5","date":"2022-05-02","type":"regulatory","source":"nature.com","summary":"Impact of the SARS-CoV-2 pandemic on female breast, colorectal and non-small cell lung cancer incidence, stage and healthcare pathway to diagnosis during 2020 in Wales, UK, using a national cancer cli","headline":"Impact of the SARS-CoV-2 pandemic on female breast, colorectal and non-small cell lung cancer incidence, stage and healt","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTE53NXpKdmxaWDN3dzVfYkFVQW9JTklfVmJoWDlmYkFuQ1dya1lrOWNGU1BKSkhfVUd1eWk3RG0xM2NCM3dzREhIemhObVZZWWNhWmllMnpmR19qbjZ5OGliZ1Uwb2tQSVdvYVJ6c3BpREJ1LVp4MW9nclNpUQ?oc=5","date":"2022-01-05","type":"trial","source":"acsjournals.onlinelibrary.wiley.com","summary":"The validity of progression‐free survival 2 as a surrogate trial end point for overall survival - acsjournals.onlinelibrary.wiley.com","headline":"The validity of progression‐free survival 2 as a surrogate trial end point for overall survival","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXkFVX3lxTE5UbDh0ZTJKcm5jVXFlcHdFQ2dtMF9aVmduTUlnSU9IdDV6eG9ZamN4Vk1vY1l2M3NXQXZfenc2LUlSdkhBanV2OE9hNktyRjBBejI0NTJXTlUwSUFwQ2c?oc=5","date":"2020-01-06","type":"trial","source":"nature.com","summary":"Effective delivery of Complex Innovative Design (CID) cancer trials—A consensus statement | British Journal of Cancer - nature.com","headline":"Effective delivery of Complex Innovative Design (CID) cancer trials—A consensus statement | British Journal of Cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxOOWtvQzhjbWF4X3VmTGlOQWUyTGhaWmxOZ1l5QWM5dnY1Y3k2Q1dfWF8tcjRjS0hjZkdhcHUwVDVuT2NvWXZuZG9wcEJTd3FIbDJaSnhrVDNxMUkxZnEteXltcXNwa2NxMW1wdWRlMUNpbkJZRm1nWi1GWVZYbC1icGVfVHJmR1ZVbGM3NGFkeEdmYWcwa2xN?oc=5","date":"2015-10-09","type":"pipeline","source":"Pharmaceutical Technology","summary":"Scientia Clinical Research Facility, University of New South Wales (UNSW) - Pharmaceutical Technology","headline":"Scientia Clinical Research Facility, University of New South Wales (UNSW)","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}